Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
Christopher A. Luckhurst, Celia Dominguez(CHDI Foundation), Marieke Lamers, Vahri Beaumont(University of Bristol), Roland W. Bürli(Covance (United Kingdom)), Michel Maillard(CHDI Foundation), Alan F. Haughan, Ignacio Muñoz-Sanjuán(CHDI Foundation), Gilles Raphy, Grant Wishart(Charles River Laboratories (United Kingdom)), Beth Ann Thomas, Andrew J. Stott, Kim L. Matthews, Dawn Yates, Omar Aziz, Perla Breccia, Michael E. Wall(Los Alamos National Laboratory), Philip M. Leonard
Cited by 46
Related Papers
Singular Value Decomposition and Principal Component Analysis
|Kluwer Academic Publishers eBooks|2005|1.2k
Design of gene circuits: lessons from bacteria
|Nature Reviews Genetics|2004|236
Allostery in a Coarse-Grained Model of Protein Dynamics
|Physical Review Letters|2005|165
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
|Journal of Medicinal Chemistry|2013|149
Scaling molecular dynamics beyond 100,000 processor cores for large‐scale biophysical simulations
|Journal of Computational Chemistry|2019|125